Search the Newsreel

BlackRock, Inc. (ALMS) reports 7.1M-share, 5.7% beneficial stake in Alumis

BlackRock, Inc. has disclosed a beneficial ownership of 7,069,502 shares of Alumis Inc. common stock, which represents a 5.7% stake in the company. The filing, a Schedule 13G, indicates that BlackRock and its subsidiaries hold these shares as a passive institutional investor, with sole …

Alumis Inc (ALMS) Cash Flow

This article provides a detailed cash flow statement for Alumis Inc (ALMS), covering annual and quarterly data for operating, investing, and financing activities. It presents financial figures such as net income, capital expenditures, and free cash flow over several fiscal quarters. The analysis also …

ALMS|Alumis Inc|Price:26.312|Chg%:-0.768

Alumis Inc. is a late-stage biopharmaceutical company focused on developing targeted therapies for immune-mediated diseases, including plaque psoriasis, systemic lupus erythematosus, multiple sclerosis, and Parkinson’s Disease. The company utilizes a proprietary data analytics platform to develop oral tyrosine kinase 2 (TYK2) inhibitors and other …

Alumis Market Sentiment

This article provides an overview of market sentiment for Alumis (ALMS), including analyst consensus, short interest, options flow, and insider activity. It highlights a "Buy" analyst consensus with an average price target of $37 and notes increasing short interest. The article also includes a …

Orbimed Advisors LLC Has $12.08 Million Stock Holdings in Alumis Inc. $ALMS

Alumis Inc. $ALMS Shares Acquired by Octagon Capital Advisors LP

Gaming Realms Expects Positive H2 Momentum as UK Revenue Rose 3%

ALMS Balance Sheet

This article provides the quarterly and annual balance sheets for Alumis Inc. (ALMS), allowing for evaluation of its financial health and key ratios. It details assets, liabilities, and shareholders' equity, covering metrics essential for assessing liquidity, leverage, and return on equity. The content also …

Alumis Inc (ALMS) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Alumis Inc (ALMS), detailing its current earnings forecast score of 9.09, ranking 12th in the Biotechnology & Medical Research industry. It highlights an average analyst price target of $18.00 with a "Buy" consensus based on 11 analysts. …

Alumis Inc (ALMS) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Alumis Inc's (ALMS) dividend history and stock split events, noting that no dividend data is available. It states that $0.00 USD has been distributed in dividends over the past 5 years for the company, indicating no payouts have …

Weiss Asset Management LP Buys New Shares in Alumis Inc. $ALMS

Alumis Inc. Revenue Breakdown – NASDAQ:ALMS

This page provides financial information for Alumis Inc. (NASDAQ: ALMS), including an overview of financials, statements, statistics, dividends, earnings, and segment performance. It highlights that market data is provided by ICE Data Services and FactSet, with SEC filings by Quartr. The primary focus is …

Sarawak Oil Palms Bhd. Revenue Breakdown – MYX:SOP

Principal Financial Group Inc. Acquires Shares of 1,058,051 Alumis Inc. $ALMS

Alumis (ALMS) Joins Growth Indices, Is The Stock Overvalued?

ALMS Forecast — Price Target — Prediction for 2027

Be Sure To Check Out Sarawak Oil Palms Berhad (KLSE:SOP) Before It Goes Ex-Dividend

Alumis Inc. (ALMS) Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Stock Reaction - Margin Guidance

ALMS Q1 2026 Earnings: EPS Surprises to the Upside Amid Pre-Revenue Clinical Stage - Earnings Season Outlook

Alumis Inc. (ALMS) Q1 2026 Earnings: Narrower Loss Mirrors Operational Discipline, Pre-Revenue Stage Persists - Slow Growth Warning

A Look At Alumis (ALMS) Valuation After Revenue Drop And Narrowed Net Loss

Raymond James and Guggenheim Stay Bullish on Alumis (ALMS) After Trial Results

Alumis (ALMS) Valuation Check After Positive Phase 3 Psoriasis Results For Envudeucitinib

Alumis (ALMS) Q4 Loss Of US$92.9 Million Tests Bullish Growth Narrative

RHB: Sarawak Oil Palms set for strongest 4Q on higher production

Alumis Inc. (ALMS) Stock Price | Live Quotes & Charts | NASDAQ

Sarawak Oil Palms Berhad (KLSE:SOP) Has Announced A Dividend Of MYR0.08

Sarawak Oil Palms' output recovery to sustain earnings

Sarawak Oil Palms shares test one-month high after 2Q surprise

Attractive Valuation with Solid Earnings, ‘BUY’ Call on Sarawak Oil Palms: RHB Research

Sarawak Oil Palms’ downstream expansion provides growth to returns

Sarawak Oil Palms proposes one-for-two bonus issue

Sarawak Oil Palms' 2Q net profit up 156% on higher palm products prices

Sarawak Oil Palm’s earnings expected to be high on CPO prices

Sarawak Plantation Berhad (5135.KL) stock price, news, quote and history